Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial [0.03%]
补遗：DESTINY-Breast09：HER2阳性晚期乳腺癌患者接受曲妥珠单抗deruxtecan治疗的IIIb/IV期临床试验结果
Nadia Harbeck,Eva Ciruelos,Guy Jerusalem et al.
Nadia Harbeck et al.
Published Erratum
Nature medicine. 2024 Dec;30(12):3780. DOI:10.1038/s41591-024-03349-0 2024
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease [0.03%]
分型的多基因风险评分可识别与代谢功能障碍相关的肝脂肪变性疾病的亚型
Oveis Jamialahmadi,Antonio De Vincentis,Federica Tavaglione et al.
Oveis Jamialahmadi et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by an excess of lipids, mainly triglycerides, in the liver and components of the metabolic syndrome, which can lead to cirrhosis and liver cancer. While there...
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease [0.03%]
数据驱动的聚类分析识别出与代谢功能障碍相关的脂肪变性肝病的不同类型
Violeta Raverdy,Federica Tavaglione,Estelle Chatelain et al.
Violeta Raverdy et al.
Metabolic dysfunction-associated steatotic liver disease (MASLD) exhibits considerable variability in clinical outcomes. Identifying specific phenotypic profiles within MASLD is essential for developing targeted therapeutic strategies. Here...
Anita Zaidi
Anita Zaidi
Hypothalamic deep brain stimulation augments walking after spinal cord injury [0.03%]
脊髓损伤后下丘脑深部脑刺激可增强步行能力
Newton Cho,Jordan W Squair,Viviana Aureli et al.
Newton Cho et al.
A spinal cord injury (SCI) disrupts the neuronal projections from the brain to the region of the spinal cord that produces walking, leading to various degrees of paralysis. Here, we aimed to identify brain regions that steer the recovery of...
Karen O&#x;Leary
Karen O&#x;Leary